T. Rowe Price Associates
DOCS icon

T. Rowe Price Associates’s Doximity DOCS Stock Holding History

T. Rowe Price Associates’s Portfolio DOCS Stock Details DOCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.71M Sell
130,425
-267,955
-67% -$5.93M ﹤0.01% 1865
2026
Q1 		$9.28M Sell
398,380
-131,543
-25% -$4.1M ﹤0.01% 1235
2025
Q4 		$23.5M Sell
529,923
-88,150
-14% -$4.95M ﹤0.01% 1028
2025
Q3 		$45.2M Buy
618,073
+509,824
+471% +$33.2M ﹤0.01% 830
2025
Q2 		$6.64M Sell
108,249
-17,968
-14% -$1M ﹤0.01% 1211
2025
Q1 		$7.33M Sell
126,217
-54,526
-30% -$3.44M ﹤0.01% 1172
2024
Q4 		$9.65M Sell
180,743
-127,483
-41% -$6.24M ﹤0.01% 1160
2024
Q3 		$13.4M Sell
308,226
-195,518
-39% -$6.52M ﹤0.01% 1087
2024
Q2 		$14.1M Sell
503,744
-56,082
-10% -$1.48M ﹤0.01% 1038
2024
Q1 		$15.1M Buy
559,826
+2,190
+0.4% +$62.4K ﹤0.01% 1041
2023
Q4 		$15.6M Sell
557,636
-93,878
-14% -$2.22M ﹤0.01% 1005
2023
Q3 		$13.8M Sell
651,514
-1,459,680
-69% -$39.8M ﹤0.01% 1006
2023
Q2 		$71.8M Sell
2,111,194
-241,542
-10% -$8.04M 0.01% 603
2023
Q1 		$76.2M Sell
2,352,736
-979,141
-29% -$32.5M 0.01% 573
2022
Q4 		$112M Sell
3,331,877
-798,829
-19% -$24.4M 0.02% 469
2022
Q3 		$125M Sell
4,130,706
-8,414,467
-67% -$308M 0.02% 450
2022
Q2 		$437M Sell
12,545,173
-126,114
-1% -$4.97M 0.06% 318
2022
Q1 		$660M Sell
12,671,287
-2,306,587
-15% -$116M 0.07% 282
2021
Q4 		$751M Buy
14,977,874
+9,821,378
+190% +$639M 0.07% 273
2021
Q3 		$416M Buy
5,156,496
+911,887
+21% +$66.7M 0.04% 376
2021
Q2 		$247M Buy
+4,244,609
New +$238M 0.02% 496

Other funds holding DOCS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

T. Rowe Price Associates's DOCS Position: Q2 2026 in Review

T. Rowe Price Associates reduced its Doximity (DOCS) stake by 67% in Q2 2026, selling an estimated $5.93M and leaving 130,425 shares worth $2.71M. The position accounts for ﹤0.01% of the portfolio, ranked #1865.

T. Rowe Price Associates first reported a position in DOCS in Q2 2021 and has held it in 21 quarters since. The position peaked at $751M in Q4 2021. 358 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

  • T. Rowe Price Associates held 130,425 shares of Doximity worth $2.71M as of Q2 2026.
  • T. Rowe Price Associates sold 267,955 Doximity shares in Q2 2026, an estimated $5.93M.
  • Doximity made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #1865 holding.
  • T. Rowe Price Associates first reported a position in Doximity in Q2 2021 and has held it in 21 quarters since.
  • T. Rowe Price Associates's Doximity position peaked at $751M in Q4 2021.
  • 358 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.